[HTML][HTML] Discovery and validation of a three-gene signature to distinguish COVID-19 and other viral infections in emergency infectious disease presentations: a case …
…, RK Gupta, EA Mills, D Arancon… - The Lancet …, 2021 - thelancet.com
Background Emergency admissions for infection often lack initial diagnostic certainty.
COVID-19 has highlighted a need for novel diagnostic approaches to indicate likelihood of viral …
COVID-19 has highlighted a need for novel diagnostic approaches to indicate likelihood of viral …
[PDF][PDF] Antiviral metabolite 3′-deoxy-3′, 4′-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19
Background There is a critical need for rapid viral infection diagnostics to enable prompt case
identification in pandemic settings and support targeted antimicrobial prescribing. Methods …
identification in pandemic settings and support targeted antimicrobial prescribing. Methods …
Differentiation of COVID-19 from other emergency infectious disease presentations using whole blood transcriptomics then rapid qPCR: a case-control and …
…, A Haber, M Amran, R Hammond, D Arancon… - medRxiv, 2023 - medrxiv.org
Background. The overlapping clinical presentations of patients with acute respiratory
disease can complicate disease diagnosis. Whilst PCR diagnostic methods to identify SARS-CoV-2 …
disease can complicate disease diagnosis. Whilst PCR diagnostic methods to identify SARS-CoV-2 …
Discovery and validation of a 3-gene transcriptional signature to distinguish COVID-19 and other viral infections from bacterial sepsis in adults; a case-control then …
…, D Habgood-Coote, RK Gupta, EA Mills, D Arancon… - 2021 - papers.ssrn.com
Background: Emergency hospital admissions for infection often lack microbiological diagnostic
certainty. Novel approaches to discriminate likelihood of bacterial and viral infections are …
certainty. Novel approaches to discriminate likelihood of bacterial and viral infections are …
Antiviral metabolite 3'-Deoxy-3', 4'-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19
There is a critical need for improved infectious disease diagnostics to enable rapid case
identification in a viral pandemic and support targeted antimicrobial prescribing. Here we use …
identification in a viral pandemic and support targeted antimicrobial prescribing. Here we use …
[PDF][PDF] Antiviral metabolite 3'-Deoxy-3', 4'-didehydro-cytidine is detectable in serum and identifies
…, H Jackson, C Sands, E Mills, D Arancon… - Infection, 2020 - researchgate.net
There is a critical need for improved infectious disease diagnostics to enable rapid case
identification in a viral pandemic and support targeted antimicrobial prescribing. Here we use …
identification in a viral pandemic and support targeted antimicrobial prescribing. Here we use …
[HTML][HTML] The reporting of pulmonary nodule results by letter in a lung cancer screening setting
JL Dickson, A Bhamani, SL Quaife, C Horst, S Tisi… - Lung Cancer, 2022 - Elsevier
Objectives Pulmonary nodules are commonly found in Lung Cancer Screening (LCS), with
results typically communicated by face-to-face or telephone consultation. Providing LCS on a …
results typically communicated by face-to-face or telephone consultation. Providing LCS on a …
[HTML][HTML] The SUMMIT Study: Utilising a written 'Next Steps' information booklet to prepare participants for potential lung cancer screening results and follow-up
A Bhamani, C Horst, F Bojang, SL Quaife, JL Dickson… - Lung Cancer, 2023 - Elsevier
Objectives Low-Dose Computed Tomography (LDCT) screening for lung cancer can result
in several potential outcomes of varying significance. Communication methods used in Lung …
in several potential outcomes of varying significance. Communication methods used in Lung …
[HTML][HTML] Utilisation of primary care electronic patient records for identification and targeted invitation of individuals to a lung cancer screening programme
JL Dickson, H Hall, C Horst, S Tisi, P Verghese… - Lung Cancer, 2022 - Elsevier
Lung cancer screening (LCS) eligibility is largely determined by tobacco consumption.
Primary care smoking data could guide LCS invitation and eligibility assessment. We present …
Primary care smoking data could guide LCS invitation and eligibility assessment. We present …
[HTML][HTML] Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk …
JL Dickson, H Hall, C Horst, S Tisi… - The Lancet Public …, 2023 - thelancet.com
Background Lung cancer screening with low-dose CT reduces lung cancer mortality, but
screening requires equitable uptake from candidates at high risk of lung cancer across ethnic …
screening requires equitable uptake from candidates at high risk of lung cancer across ethnic …
